{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:16:01Z","timestamp":1764936961252,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,12,16]],"date-time":"2017-12-16T00:00:00Z","timestamp":1513382400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Esophagus"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s10388-017-0597-1","type":"journal-article","created":{"date-parts":[[2017,12,16]],"date-time":"2017-12-16T13:45:25Z","timestamp":1513431925000},"page":"53-58","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Angiogenic factors: role in esophageal cancer, a brief review"],"prefix":"10.1007","volume":"15","author":[{"given":"K\u00e1tia","family":"Ladeira","sequence":"first","affiliation":[]},{"given":"Filipa","family":"Macedo","sequence":"additional","affiliation":[]},{"given":"Adhemar","family":"Longatto-Filho","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3526-3199","authenticated-orcid":false,"given":"Sandra F.","family":"Martins","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,12,16]]},"reference":[{"key":"597_CR1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(12)60643-6","volume":"381","author":"A Pennathur","year":"2013","unstructured":"Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma. Lancet. 2013;381:400\u201312.","journal-title":"Lancet"},{"key":"597_CR2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"A Jemal","year":"2009","unstructured":"Jemal A, Siegel R, Ward E, et al. Cancer statistics 2009. CA Cancer Clin. 2009;59:225\u201349.","journal-title":"CA Cancer Clin"},{"key":"597_CR3","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860\u20137.","journal-title":"Nature"},{"key":"597_CR4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"597_CR5","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ctrv.2012.04.007","volume":"38","author":"Y Guo","year":"2012","unstructured":"Guo Y, Xu F, Lu T, et al. Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev. 2012;38:904\u201310.","journal-title":"Cancer Treat Rev"},{"key":"597_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.immunol.23.021704.115806","volume":"23","author":"T Kishimoto","year":"2005","unstructured":"Kishimoto T. Interleukin-6: from basic science to medicine 40\u00a0years in immunology. Annu Rev Immunol. 2005;23:1\u201321.","journal-title":"Annu Rev Immunol"},{"key":"597_CR7","first-page":"389","volume":"16","author":"Y Oshima","year":"2010","unstructured":"Oshima Y, Yajima S, Yamazaki K, et al. Angiogenesis-related factors are molecular targets for diagnosis and treatment of patients with esophageal carcinoma. Ann Thorac Cardiovasc Surg. 2010;16:389\u201393.","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"597_CR8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3892\/ol.2013.1409","volume":"6","author":"Z Xu","year":"2013","unstructured":"Xu Z, Wang S, Wu M, et al. TGF beta1 and HGF protein secretion by esophageal squamous epithelial cells and stromal fibroblasts in oesophageal carcinogenesis. Oncol Lett. 2013;6:401\u20136.","journal-title":"Oncol Lett"},{"key":"597_CR9","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.3748\/wjg.v11.i14.2188","volume":"11","author":"K Sugiura","year":"2005","unstructured":"Sugiura K, Ozawa S, Kitagawa Y, et al. Co-expression of aFGF and FGFR-1 is predictive of a poor prognosis in patients with esophageal cancer. World J Gastroenterol. 2005;11:2188\u201392.","journal-title":"World J Gastroenterol"},{"key":"597_CR10","first-page":"467","volume":"11","author":"J Folkman","year":"1986","unstructured":"Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? Cancer Res. 1986;11:467\u201373.","journal-title":"Cancer Res"},{"key":"597_CR11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.semradonc.2004.04.007","volume":"14","author":"C Leo","year":"2004","unstructured":"Leo C, Giaccia AJ, Denko NC. The hypoxic tumor microenvironment and gene expression. Semin Radiat Oncol. 2004;14:207\u201314.","journal-title":"Semin Radiat Oncol"},{"key":"597_CR12","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.ejca.2004.04.035","volume":"40","author":"S Kimura","year":"2004","unstructured":"Kimura S, Kitadai Y, Tanaka S, et al. Expression of hypoxia inducible factor (HIF)-1\u03b1 is associated with vascular endothelial growth factor expression and tumour angiogenesis in human oesophageal squamous cell carcinoma. Eur J Cancer. 2004;40:1904\u201312.","journal-title":"Eur J Cancer"},{"key":"597_CR13","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrm1261","volume":"4","author":"C Birchmeier","year":"2003","unstructured":"Birchmeier C, Birchmeier W, Gherardi E, et al. Metastasis, motility and more. Nat Rev Mol Cell Biol. 2003;4:915\u201325.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"597_CR14","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1126\/science.1846706","volume":"251","author":"DP Bottaro","year":"1991","unstructured":"Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 1991;251:802\u20134.","journal-title":"Science"},{"key":"597_CR15","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.1158\/1078-0432.CCR-04-2553","volume":"3","author":"Yi Ren","year":"2005","unstructured":"Ren Yi, Cao Brian, Law Simon, et al. Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas. Clin Cancer Res. 2005;3:6190\u20137.","journal-title":"Clin Cancer Res"},{"key":"597_CR16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ijc.10163","volume":"98","author":"H Saeki","year":"2002","unstructured":"Saeki H, Oda S, Kawaguchi H, et al. Concurrent overexpression of Ets-1 and c-Met correlates with a phenotype of high cellular motility in human esophageal cancer. Int J Cancer. 2002;98:8\u201313.","journal-title":"Int J Cancer"},{"key":"597_CR17","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/00029330-200707020-00002","volume":"120","author":"YZ Zhou","year":"2007","unstructured":"Zhou YZ, Fang XQ, Li H, et al. Role of serum angiopoietin-2 level in screening for esophageal squamous cell cancer and its precursors. Chin Med J (Engl). 2007;120:1216\u20139.","journal-title":"Chin Med J (Engl)"},{"key":"597_CR18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12885-015-1120-5","volume":"15","author":"L Dreikhausen","year":"2015","unstructured":"Dreikhausen L, Blank S, Sisic L, et al. Association of angiogenic factors with prognosis in esophageal cancer. BMC Cancer. 2015;15:121\u20137.","journal-title":"BMC Cancer"},{"key":"597_CR19","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1172\/JCI0215617","volume":"109","author":"J Bromberg","year":"2002","unstructured":"Bromberg J. Stat proteins and oncogenesis. J Clin Invest. 2002;109:1139\u201342.","journal-title":"J Clin Invest"},{"key":"597_CR20","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3892\/ol.2015.3990","volume":"11","author":"Z-F Zhao","year":"2016","unstructured":"Zhao Z-F, Li J-X, Ye Rui, et al. Interleukin-6 as a potential molecular target in esophageal squamous cell carcinoma. Oncol Lett. 2016;11:925\u201332.","journal-title":"Oncol Lett"},{"key":"597_CR21","doi-asserted-by":"crossref","first-page":"20059","DOI":"10.1074\/jbc.R700016200","volume":"282","author":"C Schindler","year":"2007","unstructured":"Schindler C, Levy DE, Decker T. JAK-STAT signaling, from interferons to cytokines. J Biol Chem. 2007;282:20059\u201363.","journal-title":"J Biol Chem"},{"key":"597_CR22","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0891-5849(02)01045-6","volume":"1","author":"C Michiels","year":"2002","unstructured":"Michiels C, Minet E, Mottet D, et al. Regulation of gene expression by oxygen: NF-kappaB and HIF-1, two extremes. Free Radic Biol Med. 2002;1:1231\u201342.","journal-title":"Free Radic Biol Med"},{"key":"597_CR23","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","volume":"1","author":"GL Wang","year":"1995","unstructured":"Wang GL, Jiang BH, Rue EA, et al. Hypoxia inducible factor 1 is a basic helix-loop-helix\u2013PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA. 1995;1:5510\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"597_CR24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/28867","volume":"394","author":"P Carmeliet","year":"1998","unstructured":"Carmeliet P, Dor Y, Herbert JM, et al. Role of HIF-1\u03b1 in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis. Nature. 1998;394:485\u201390.","journal-title":"Nature"},{"key":"597_CR25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/scbi.1998.0091","volume":"9","author":"T Veikkola","year":"1999","unstructured":"Veikkola T, Alitalo K. VEGFs, receptors and angiogenesis. Semin Cancer Biol. 1999;9:211\u201320.","journal-title":"Semin Cancer Biol"},{"key":"597_CR26","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm0603-677","volume":"9","author":"CW Pugh","year":"2003","unstructured":"Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med. 2003;9:677\u201384.","journal-title":"Nat Med"},{"key":"597_CR27","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1091\/mbc.10.4.907","volume":"10","author":"JA Dibbens","year":"1999","unstructured":"Dibbens JA, Miller DL, Damert A, et al. Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements. Mol Biol Cell. 1999;10:907\u201319.","journal-title":"Mol Biol Cell"},{"key":"597_CR28","first-page":"39","volume":"15","author":"LM Ellis","year":"2001","unstructured":"Ellis LM, Liu W, Fan F, et al. Role of angiogenesis inhibitors in cancer treatment. Oncology (Williston Park). 2001;15:39\u201346.","journal-title":"Oncology (Williston Park)"},{"key":"597_CR29","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0959-8049(02)00106-5","volume":"15","author":"T Amioka","year":"2002","unstructured":"Amioka T, Kitadai Y, Tanaka S, et al. Vascular endothelial growth factor- C expression predicts lymph node metastasis of human gastric carcinoma invading the submucosa. Eur J Cancer. 2002;15:1413\u20139.","journal-title":"Eur J Cancer"},{"key":"597_CR30","first-page":"5830","volume":"59","author":"H Zhong","year":"1999","unstructured":"Zhong H, De Marzo AM, Laughner E, et al. Over-expression of hypoxia-inducible factor 1\u03b1 in common human cancers and their metastases. Cancer Res. 1999;59:5830\u20135.","journal-title":"Cancer Res"},{"key":"597_CR31","first-page":"2911","volume":"12","author":"DM Aebersold","year":"2001","unstructured":"Aebersold DM, Burri P, Beer KT, et al. Expression of hypoxia-inducible factor-1 alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res. 2001;12:2911\u20136.","journal-title":"Cancer Res"},{"key":"597_CR32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1155\/2008\/468323","volume":"25","author":"C Tzao","year":"2008","unstructured":"Tzao C, Lee S-C, Tung H-J, et al. Expression of hypoxia-inducible factor (HIF)-1alpha and vascular endothelial growth factor (VEGF)-D as outcome predictors in resected esophageal squamous cell carcinoma. Dis Markers. 2008;25:141\u20138.","journal-title":"Dis Markers"},{"key":"597_CR33","doi-asserted-by":"crossref","first-page":"16768","DOI":"10.1073\/pnas.0407617101","volume":"101","author":"BZ Olenyuk","year":"2004","unstructured":"Olenyuk BZ, Zhang GJ, Klco JM, et al. Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist. Proc Natl Acad Sci USA. 2004;101:16768\u201373.","journal-title":"Proc Natl Acad Sci USA"},{"key":"597_CR34","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1158\/0008-5472.605.65.2","volume":"65","author":"C Tan","year":"2005","unstructured":"Tan C, de Noronha RG, Roecker AJ, et al. Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway. Cancer Res. 2005;65:605\u201312.","journal-title":"Cancer Res"},{"key":"597_CR35","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1158\/1078-0432.CCR-07-0647","volume":"355","author":"A Sandler","year":"2007","unstructured":"Sandler A. Bevacizumab in non-small cell lung cancer. Clin Cancer Res. 2007;355:4613\u20136.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"597_CR36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.21037\/jgo.2016.11.13","volume":"8","author":"P Samson","year":"2017","unstructured":"Samson P, Lockhart AC. Biologic therapy in esophageal and gastric malignancies: current therapies and future directions. J Gastrointest Oncol. 2017;8(3):418\u201329.","journal-title":"J Gastrointest Oncol"},{"key":"597_CR37","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1146\/annurev.biochem.67.1.753","volume":"67","author":"J Massagu\u00e9","year":"1998","unstructured":"Massagu\u00e9 J. TGF-\u03b2 signal transduction. Annu Rev Biochem. 1998;67:753\u201391.","journal-title":"Annu Rev Biochem"},{"key":"597_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08977199308991577","volume":"9","author":"H Lahm","year":"1993","unstructured":"Lahm H, Odartchenko N. Role of transforming growth factor \u03b2 in colorectal cancer. Growth Factors. 1993;9:1\u20139.","journal-title":"Growth Factors"},{"key":"597_CR39","first-page":"9624","volume":"7","author":"I S.-W","year":"2000","unstructured":"S.-W I, Volpert OV, Bouck NP, et al. Smad4\/DPC4-mediated tumor suppression through suppression of angiogenesis. Proc Natl Acad Sci USA. 2000;7:9624\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"597_CR40","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/1097-0142(19940501)73:9<2275::AID-CNCR2820730907>3.0.CO;2-T","volume":"73","author":"Y Shirai","year":"1994","unstructured":"Shirai Y, Kawata S, Tamura S, et al. Plasma transforming growth factor-\u03b2 1 in patients with hepatocellular carcinoma comparison with chronic liver diseases. Cancer (Phila). 1994;73:2275\u20139.","journal-title":"Cancer (Phila)"},{"key":"597_CR41","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1006\/cyto.1996.0105","volume":"8","author":"U Junker","year":"1996","unstructured":"Junker U, Knoefel B, Nuske K, et al. Transforming growth factor-\u03b2 1 is significantly elevated in plasma of patients suffering from renal cell carcinoma. Cytokine. 1996;8:794\u20138.","journal-title":"Cytokine"},{"key":"597_CR42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/gast.1996.v110.pm8566583","volume":"110","author":"H Tsushima","year":"1996","unstructured":"Tsushima H, Kawata S, Tamura S, et al. High levels of transforming growth factor-\u03b2 1 in patients with colorectal cancer: association with disease progression. Gastroenterology. 1996;110:375\u201382.","journal-title":"Gastroenterology"},{"key":"597_CR43","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1455::AID-CNCR11>3.0.CO;2-L","volume":"86","author":"H Saito","year":"1999","unstructured":"Saito H, Tsujitani S, Oka S, et al. The expression of transforming growth factor-\u03b21 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. Cancer (Phila). 1999;86:1455\u201362.","journal-title":"Cancer (Phila)."},{"key":"597_CR44","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1002\/1097-0142(20011215)92:12<2985::AID-CNCR10175>3.0.CO;2-5","volume":"92","author":"SF Shariat","year":"2001","unstructured":"Shariat SF, Kim JH, Andrews B, et al. Preoperative plasma levels of transforming growth factor-\u03b2 1 strongly predict clinical outcome in patients with bladder carcinoma. Cancer (Phila). 2001;92:2985\u201392.","journal-title":"Cancer (Phila)."},{"key":"597_CR45","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/ijc.1631","volume":"97","author":"S Narai","year":"2002","unstructured":"Narai S, Watanabe M, Hasegawa H, et al. Significance of transforming growth factor-\u03b21 as a new tumor marker for colorectal cancer. Int J Cancer. 2002;97:508\u201311.","journal-title":"Int J Cancer"},{"key":"597_CR46","first-page":"1838","volume":"8","author":"S Natsugoe","year":"2002","unstructured":"Natsugoe S, Xiangming C, Matsumoto M, et al. Smad4 and transforming growth factor-\u03b21 expression in patients with squamous cell carcinoma of the esophagus. Clin Cancer Res. 2002;8:1838\u201342.","journal-title":"Clin Cancer Res"},{"key":"597_CR47","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/BF01627765","volume":"13","author":"JM Chevallier","year":"1991","unstructured":"Chevallier JM, Vitte E, Derosier C, et al. The thoracic esophagus: sectional anatomy and radiosurgical applications. Surg Radiol Anat. 1991;13:313\u201321.","journal-title":"Surg Radiol Anat"},{"key":"597_CR48","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1158\/1078-0432.CCR-1096-03","volume":"10","author":"M Fukuchi","year":"2004","unstructured":"Fukuchi M, Miyazaki T, Fukai Y, et al. Plasma level of transforming growth factor-\u03b21 measured from the azygos vein predicts prognosis in patients with esophageal cancer. Clin Cancer Res. 2004;10:2738\u201341.","journal-title":"Clin Cancer Res"},{"key":"597_CR49","first-page":"617","volume":"14","author":"T Nakamura","year":"2005","unstructured":"Nakamura T, Ozawa S, Kitagawa Y, et al. Expression of basic fibroblast growth factor is associated with a good outcome in patients with squamous cell carcinoma of the esophagus. Oncol Rep. 2005;14:617\u201323.","journal-title":"Oncol Rep"}],"container-title":["Esophagus"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10388-017-0597-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10388-017-0597-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10388-017-0597-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T18:24:15Z","timestamp":1660155855000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10388-017-0597-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,16]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["597"],"URL":"https:\/\/doi.org\/10.1007\/s10388-017-0597-1","relation":{},"ISSN":["1612-9059","1612-9067"],"issn-type":[{"type":"print","value":"1612-9059"},{"type":"electronic","value":"1612-9067"}],"subject":[],"published":{"date-parts":[[2017,12,16]]}}}